Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma.
Nijhuis A, Sikka A, Yogev O, Herendi L, Balcells C, Ma Y, Poon E, Eckold C, Valbuena GN, Xu Y, Liu Y, da Costa BM, Gruet M, Wickremesinghe C, Benito A, Kramer H, Montoya A, Carling D, Want EJ, Jamin Y, Chesler L, Keun HC.
Nijhuis A, et al. Among authors: ma y.
Nat Commun. 2022 Mar 16;13(1):1380. doi: 10.1038/s41467-022-28907-3.
Nat Commun. 2022.
PMID: 35296644
Free PMC article.